¹Service d'Hématologie Biologique, Hôpital Avicenne, France

²URA 625, Hôpital Pitié-Salpétrière, France

^aAuthor for correspondence: Service d'Hématologie Biologique, Hôpital Avicenne, Bobigny, France

In order to understand the role of NF-B in EBV transformation we have established stably transfected IB into lymphoblastoid cells. Two clones were obtained in which the loss of NF-B binding activity correlated with the constitutive expression of the transgenic IB. Protein latency expression was determined by immunocytochemistry. Expression of surface markers, intracytoplasmic content of cytokines cell cycle analysis after BrdU incorporation and DNA staining with propidium iodide were studied by flow cytometry. Percentage of apoptotic cells was determined by in-situ labelling of DNA strand breaks. No significative changes in EBV latency nor in cell surface marker expression was found. In contrast, intracytoplasmic TNF levels were strongly reduced in transfected clones. Furthermore, 30% of IB transfected cells were apoptotic after 8 h of TNF treatment. This correlated with a strong reduction of BrdU incorporation after 24 h of TNF treatment. No effect was seen with non transfected cells or with cells transfected with a control plasmid. Our results suggest that the TNF gene could be one of the targets of NF-B in EBV infected cells and that NF-B protects EBV-infected cells from apoptosis induced by TNF, which may favour the proliferative effect of this cytokine.

NF-B; IB; EBV; TNF